Investor mix
4 investors on record; lead investors include Horizons Ventures, Venrock.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 100% |
Developer of biotherapeutic products for immune and metabolic disease
4 investors on record; lead investors include Horizons Ventures, Venrock.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 100% |